Pykus Therapeutics Inc.
PrivateLast Round
Grant
Mar 1, 2023
Total Funding Raised
$2.64M
Company Overview
Pykus Therapeutics Inc. is a clinical-stage medical technology company developing biodegradable polymers to provide solutions for unmet needs in vitreoretinal surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pykus Therapeutics Inc. Comparables
Compare Pykus Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geuder AG | 71% | |
| Bausch + Lomb Corporation | 70% | |
| BVI Medical | 65% | |
Pykus Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2023 | ||||
| Seed | Feb 4, 2021 | ||||
| Grant | Nov 2, 2017 | ||||
| Grant | May 4, 2016 |
Key People
Founding team and executive leadership
Pykus Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SideCar Angels | Seed |
| Bertarelli Foundation | Grant |
| Beacon Angels | Seed |
| Mass General Brigham Innovation | Seed |
| MassChallenge Israel | Grant |
| Astellas Venture Management | Seed |
| ShangBay Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2025
Initial data on novel retinal sealant PYK-2101 to be presented at Vail Vitrectomy 2025.
- Feb 10, 2025
Will present at the Vail Vitrectomy 2025 Meeting.
Pykus Therapeutics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pykus Therapeutics Inc.'s valuation, stock price, and market status.